{"name":"再鼎医药","code":"09688.HK","ipoTimeTable":{"title":"招股日程","content":[{"offerPeriod":"2020/09/17 - 2020/09/22"},{"priceSet":"2020/09/22"},{"allotment":"2020/09/25"},{"refund":"2020/09/25"},{"listing":"2020/09/28"}]},"companyInfo":{"title":"公司资料","content":[{"market":"香港联合交易所有限公司 (主板)"},{"industry":"生物科技"},{"background":"其他"},{"businessArea":"全球"},{"website":"http://www.zailaboratory.com/"}]},"ipoInfo":{"title":"招股资料","content":[{"lotSize":"50"},{"offerPrice":"648.00"},{"marketCap":"55,688,835,528"},{"offerShares":"771700(7.3%)"},{"sponsor":"J.P. Morgan Securities (Far East) Limited、花旗环球金融亚洲有限公司、高盛(亚洲)有限责任公司"},{"underwriter":"J.P. Morgan Securities (Asia Pacific) Limited、高盛(亚洲)有限责任公司、花旗环球金融亚洲有限公司、富瑞金融集团香港有限公司、Merrill Lynch (Asia Pacific) Limited、Credit Suisse (Hong Kong) Limited、中国国际金融香港证券有限公司、海通国际证券有限公司"},{"whiteForm":"N/A"},{"eIPO":"http://www.eipo.com.hk"}]}}